Related Experiment Videos
[Diagnostic image (53). Facioscapulohumeral muscle dystrophy]
1Academisch Medisch Centrum, afd. Neurologie, Postbus 22.660, 1100 DD Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|September 20, 2001
Summary
Facioscapulohumeral muscular dystrophy (FSHD) is a progressive muscle-weakening disorder. This case study details the diagnosis of a 39-year-old male patient with FSHD.
Area of Science:
- Neurology
- Genetics
- Musculoskeletal Disorders
Background:
- Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant inherited disorder.
- It is characterized by progressive skeletal muscle weakness and atrophy, typically affecting the face, shoulders, and upper arms.
- Diagnosis often relies on clinical presentation, family history, and genetic testing.
Observation:
- A 39-year-old male presented with symptoms consistent with muscular dystrophy.
- Clinical examination revealed facial muscle weakness, scapular winging, and upper limb muscle atrophy.
- The patient's medical history and physical findings prompted further investigation for FSHD.
Findings:
- Diagnostic workup confirmed the patient's diagnosis of facioscapulohumeral muscular dystrophy.
- Genetic analysis identified the characteristic epigenetic changes associated with FSHD, specifically related to the DUX4 gene.
- The patient's presentation aligns with the typical phenotype of FSHD.
Implications:
- Early and accurate diagnosis of FSHD is crucial for patient management and genetic counseling.
- Understanding the genetic basis of FSHD aids in developing targeted therapies.
- This case highlights the importance of recognizing FSHD in adult patients presenting with progressive muscle weakness.